Digital Health Startup Trials.ai Secures Pre-Seed Funding to Optimize Clinical Trial Protocols with AI

VCBeat (WeChat Official Account:vcbeat) According to foreign media reports, local time2019Year11Month15Day, Digital Health CompanyTrials.aiAnnounced the completion of its pre-seed funding round, which was led byTeal VenturesLead Investor,Amplify.LA、Sway VenturesandNex CubedParticipated in co-investment. Specific financial details have not yet been disclosed.

Digital health company Trials.ai, which optimizes the clinical trial ecosystem through cutting-edge technologies and its intelligent protocol solutions, previously secured $1.3 million in oversubscribed funding. This capital has been deployed to implement its AI-powered software, intelligently guiding research teams in designing their clinical trial protocols. Following this financing round, Trials.ai’s total funds raised will reach $2 million.

Kim Walpole, CEO of Trials.ai, stated, “The cost of advancing a single drug candidate into late-stage clinical trials typically exceeds $2 billion. Unfortunately, nearly half of all clinical trials fail due to poor design. This means that billions of dollars are wasted annually on preventable errors. Our mission is to deliver effective treatments to patients more rapidly by leveraging AI to provide critical insights from vast datasets to outstanding research teams.”

It is reported that Trials.ai is the fourth company in Teal Ventures Fund I’s portfolio, which previously added 19Labs, Mobile Medical Office, and Neuralace.

Ron Demuth, Partner at Teal Ventures, stated, “Trials.ai is an excellent example of the type of startup we seek. Its CEO, Kim Walpole, is a seasoned startup leader who has attracted top-tier employees and advisors, which is crucial to Trials.ai’s rapid growth. Trials.ai believes that AI-driven process optimization and innovation integrate clinical trials into the healthcare ecosystem. Market validation confirms that the concept behind Trials.ai holds strong commercial appeal.”

Teal Ventures is a venture capital firm specializing in early-stage investments in health technology. In the early stages of startups, Teal Ventures partners with top-tier entrepreneurs to drive breakthrough innovations in medical technology. The firm focuses on enabling digital health services through 5G communications, AI-driven decision support and process automation, as well as blockchain for business process automation.

Amplify.LA is a seed fund based in Venice, California, dedicated to supporting strong teams at the earliest stages. Founded in 2011, the firm has backed dozens of companies, helping them raise over $1 billion in total funding, with exits including Apple, Google, and FanDuel.

Sway Ventures is a U.S.-based venture capital firm that primarily invests in early- to mid-stage technology companies. The firm is dedicated to backing high-performing teams and companies building revolutionary technologies.

Nex Cubed is a seed-stage investor focused on frontier technologies. It provides hundreds of founders, mentors, investors, and corporate partners with access to resources that help entrepreneurs drive technological innovation and value growth. More than 50% of the startups in its portfolio are led by female and minority founders.

(Compiled by Xiong Hui)